Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Regulations for In Vivo Radiopharmaceuticals Used for Diagnosis and Monitoring

Özet

The Food and Drug Administration (FDA) is announcing that a collection of information entitled, "Regulations for In Vivo Radiopharmaceuticals Used for Diagnosis and Monitoring" has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995.